Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new UVA Cancer Center research ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Stanford scientists have identified 380 key genetic variants that significantly influence cancer development, filtering ...

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer today announced that it, along with its partner Moffitt ...